Comment
doi: 10.1016/j.ijantimicag.2020.106063.
Epub 2020 Jul 13.
Review of: "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949
Affiliations
- PMID: 32674928
- PMCID: PMC7357515
- DOI: 10.1016/j.ijantimicag.2020.106063
Item in Clipboard
Comment
Review of: "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949
Int J Antimicrob Agents.
2020 Jul.
No abstract available
Conflict of interest statement
Declaration of Competing Interests The author has no competing interest relevant to this paper.
Comment in
-
Practical implementation of COVID-19 patient flags into an antimicrobial stewardship program's prospective review.Infect Control Hosp Epidemiol. 2020 Sep;41(9):1108-1110. doi: 10.1017/ice.2020.133. Epub 2020 Apr 15. Infect Control Hosp Epidemiol. 2020. PMID: 32290883 Free PMC article. No abstract available.
-
Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA).Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):7923-7924. doi: 10.26355/eurrev_202008_22473. Eur Rev Med Pharmacol Sci. 2020. PMID: 32767316 No abstract available.
Comment on
-
RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20. Int J Antimicrob Agents. 2020. Retraction in: Int J Antimicrob Agents. 2025 Jan;65(1):107416. doi: 10.1016/j.ijantimicag.2024.107416. PMID: 32205204 Free PMC article. Retracted. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
